J. Ferreres

发表

Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis

Alejandro Jiménez, J. Paramo, J. Blanquer, 2009, Critical care.

Pulmonary tumor embolism as an initial manifestation of pancreatic adenocarcinoma.

J. Blanquer, J. N. Sancho-Chust, J. Ferreres, 2009, Respiratory care.

Model-Agnostic Process Modeling Master Thesis

J. Vargas, J. Ferreres, L. Cirera, 2018 .

Combined kinetic analysis of SARS-CoV-2 RNAemia, N-antigenemia and virus-specific antibodies in critically ill adult COVID-19 patients

E. Albert, E. Giménez, D. Navarro, 2022, Scientific Reports.

SARS‐CoV‐2 N‐antigenemia in critically ill adult COVID‐19 patients: Frequency and association with inflammatory and tissue‐damage biomarkers

E. Albert, D. Navarro, R. Gozalbo-Rovira, 2021, Journal of medical virology.

SARS-CoV-2 RNA load in the lower respiratory tract, viral RNAemia and N-antigenemia in critically ill adult COVID-19 patients: relationship with biomarkers of disease severity

E. Albert, D. Navarro, I. Torres, 2021, medRxiv.

Percutaneous treatment of pulmonary embolism during pregnancy.

J. Sanchis, E. Valero, N. Carbonell, 2020, Revista espanola de cardiologia.

Autoantibodies against type I IFNs in patients with critical influenza pneumonia

J. Casanova, M. Zins, L. Notarangelo, 2022, The Journal of experimental medicine.

SARS-CoV-2-reactive IFN-γ-producing CD4+ and CD8+ T cells in blood do not correlate with clinical severity in unvaccinated critically ill COVID-19 patients

E. Albert, E. Giménez, D. Navarro, 2022, Scientific Reports.

Reconnection to mechanical ventilation for 1 h after a successful spontaneous breathing trial reduces reintubation in critically ill patients: a multicenter randomized controlled trial

R. Fernandez, R. Tomás, A. González-Castro, 2017, Intensive Care Medicine.

Monitoring of Torque Teno virus DNAemia in critically ill COVID-19 patients: May it help to predict clinical outcomes?

E. Albert, E. Giménez, D. Navarro, 2022, Journal of Clinical Virology.

Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.

J. González-Martín, J. Villar, C. Ferrando, 2020, The Lancet. Respiratory medicine.

Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression

F. Pallardó, F. Sanchis-Gomar, J. García-Giménez, 2020, Antioxidants.

Epigenetic biomarkers for human sepsis and septic shock: insights from immunosuppression.

F. Pallardó, C. Romá-Mateo, J. García-Giménez, 2020, Epigenomics.

Septic patients with mitochondrial DNA haplogroup JT have higher respiratory complex IV activity and survival rate.

E. Ruiz-Pesini, J. Montoya, J. Solé-Violán, 2016, Journal of critical care.

Comparative Analysis of Chromatin-Delivered Biomarkers in the Monitoring of Sepsis and Septic Shock: A Pilot Study

Á. Montoya, F. Pallardó, C. Romá-Mateo, 2021, International journal of molecular sciences.

Sepsis and Coronavirus Disease 2019: Common Features and Anti-Inflammatory Therapeutic Approaches

F. Pallardó, J. García-Giménez, J. Beltrán-García, 2020, Critical care medicine.

ESICM LIVES 2016: part two

A. M. Cavalheiro, H. S. King, M. M. Moraes, 2016, Intensive Care Medicine Experimental.

Should MASP-2 Deficiency Be Considered a Primary Immunodeficiency? Relevance of the Lectin Pathway

F. Rodríguez de Castro, C. Muñoz-Almagro, C. Rodríguez-Gallego, 2019, Journal of Clinical Immunology.

Association between DNA and RNA oxidative damage and mortality in septic patients.

P. Abreu-González, J. Solé-Violán, L. Lorente, 2019, Journal of critical care.

Sustained high plasma plasminogen activator inhibitor-1 levels are associated with severity and mortality in septic patients.

J. Paramo, J. Solé-Violán, L. Lorente, 2014, Thrombosis research.

Sustained high serum malondialdehyde levels are associated with severity and mortality in septic patients

A. Domínguez-Rodríguez, P. Abreu-González, J. Solé-Violán, 2013, Critical Care.

Serum total antioxidant capacity during the first week of sepsis and mortality

P. Abreu-González, J. Solé-Violán, L. Lorente, 2018, Journal of critical care.

Red Blood Cell Distribution Width during the First Week Is Associated with Severity and Mortality in Septic Patients

P. Abreu-González, J. Solé-Violán, L. Lorente, 2014, PloS one.

Mini-bronchoalveolar lavage (mini-BAL) in the cytological diagnosis of interstitial disorders with acute respiratory failure and mechanical ventilation.

J. Blanquer, J. N. Sancho-Chust, J. Ferreres, 2010, Archivos de Bronconeumologia.

Non‐survivor septic patients have persistently higher serum sCD40L levels than survivors

J. Solé-Violán, L. Lorente, María M. Martín, 2017, Journal of critical care.

Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis

J. Paramo, J. Blanquer, J. Orbe, 2011, Critical care.

Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis

J. Paramo, J. Blanquer, J. Orbe, 2011, Critical care.

Lower mitochondrial dysfunction in survivor septic patients with mitochondrial DNA haplogroup JT.

E. Ruiz-Pesini, J. Montoya, J. Solé-Violán, 2017, Enfermedades infecciosas y microbiologia clinica.

Higher serum caspase-cleaved cytokeratin-18 levels during the first week of sepsis diagnosis in non-survivor patients

J. Solé-Violán, L. Lorente, María M. Martín, 2017, Clinical chemistry and laboratory medicine.

Characterization of Early Peripheral Immune Responses in Patients with Sepsis and Septic Shock

J. O'connor, F. Pallardó, Guadalupe Herrera, 2022, Biomedicines.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients.

M. Fernández, A. Mesejo, F. López, 2003, Clinical nutrition.

Association between serum substance P levels and mortality in patients with severe sepsis.

J. Solé-Violán, L. Lorente, María M. Martín, 2015, Journal of critical care.

Lower mitochondrial dysfunction in survivor septic patients with mitochondrial DNA haplogroup JT

E. Ruiz-Pesini, J. Montoya, J. Solé-Violán, 2018, Enfermedades infecciosas y microbiologia clinica (English ed.).

Sustained high serum caspase-3 concentrations and mortality in septic patients

J. Solé-Violán, L. Lorente, María M. Martín, 2017, European Journal of Clinical Microbiology & Infectious Diseases.

Sustained Low Serum Substance P Levels in Non-Surviving Septic Patients

J. Solé-Violán, L. Lorente, María M. Martín, 2017, International journal of molecular sciences.

Association between Interleukin-6 Promoter Polymorphism (-174 G/C), Serum Interleukin-6 Levels and Mortality in Severe Septic Patients

J. Solé-Violán, L. Lorente, María M. Martín, 2016, International journal of molecular sciences.

Serum caspase 3 levels are associated with early mortality in severe septic patients.

J. Solé-Violán, L. Lorente, María M. Martín, 2016, Journal of critical care.

Association between serum total antioxidant capacity and mortality in severe septic patients.

P. Abreu-González, J. Solé-Violán, L. Lorente, 2015, Journal of critical care.

Serum Levels of Caspase-Cleaved Cytokeratin-18 and Mortality Are Associated in Severe Septic Patients: Pilot Study

J. Solé-Violán, L. Lorente, María M. Martín, 2014, PloS one.

Prognostic Value of Malondialdehyde Serum Levels in Severe Sepsis: A Multicenter Study

A. Domínguez-Rodríguez, P. Abreu-González, J. Solé-Violán, 2013, PloS one.

Platelet cytochrome c oxidase activity and quantity in septic patients*

E. Ruiz-Pesini, J. Montoya, J. Blanquer, 2011, Critical care medicine.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: Relationship with biomarkers of disease severity

E. Albert, D. Navarro, R. Gozalbo-Rovira, 2021, Journal of Infection.

Neurally adjusted ventilatory assist in acute respiratory failure: a randomized controlled trial

R. Kacmarek, J. González-Martín, J. Villar, 2020, Intensive Care Medicine.

Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial

Arthur S Slutsky, K. Thorpe, J. Villar, 2020, Trials.

Sepsis and SOFA score: related outcome for critically ill renal patients.

A. Miguel, J. Blanquer, N. Carbonell, 2004, Clinical Nephrology.

Validation of circulating histone detection by mass spectrometry for early diagnosis, prognosis, and management of critically ill septic patients

F. Pallardó, Oreto Antúnez, C. Romá-Mateo, 2023, Journal of Translational Medicine.

Ceftolozane Pharmacokinetics in a Septic Critically Ill Patient under Different Extracorporeal Replacement Therapies

M. Blasco, N. Carbonell, M. Calabuig, 2019, Antimicrobial Agents and Chemotherapy.

The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis

J. Solé-Violán, L. Lorente, María M. Martín, 2015, PloS one.

Serum melatonin levels are associated with mortality in severe septic patients.

P. Abreu-González, J. Solé-Violán, L. Lorente, 2015, Journal of critical care.

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Mark S. Anderson, P. Gregersen, R. Nussbaum, 2021, Science Immunology.

Serum melatonin levels during the first seven days of severe sepsis diagnosis are associated with sepsis severity and mortality

P. Abreu-González, J. Solé-Violán, L. Lorente, 2018, Enfermedades infecciosas y microbiologia clinica (English ed.).

Serum melatonin levels during the first seven days of severe sepsis diagnosis are associated with sepsis severity and mortality.

P. Abreu-González, J. Solé-Violán, L. Lorente, 2017, Enfermedades infecciosas y microbiologia clinica.

A genome-wide association study of adults with community-acquired pneumonia

I. Marcelino-Rodriguez, C. Rodríguez-Gallego, L. Borderías, 2023, medRxiv.

Challenges in understanding host genetics and severity of community-acquired pneumonia

F. Rodríguez de Castro, J. González-Martín, C. Rodríguez-Gallego, 2020, ERJ Open Research.

Rationale for combined therapies in severe-to-critical COVID-19 patients

A. Hmadcha, J. M. Sempere-Ortells, R. Goterris, 2023, Frontiers in Immunology.

ESICM LIVES 2016: part two

A. M. Cavalheiro, H. S. King, H. Z. Chai, 2016, Intensive care medicine experimental.

Platelet cytochrome c oxidase activity and quantity in septic patients*

E. Ruiz-Pesini, J. Montoya, J. Blanquer, 2011, Critical care medicine.

Serum caspase 3 levels are associated with early mortality in severe septic patients.

J. Solé-Violán, L. Lorente, María M. Martín, 2016, Journal of critical care.

EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndrome

N. Carbonell, M. Calabuig, C. Carretero, 2024, Clinical Neurophysiology.